Treace Medical Concepts Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
May 07, 2024 16:05 ET
|
Taysha Gene Therapies, Inc.
DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the...
Opus Partners with New Relic to Enhance Secure Developer Experience
May 07, 2024 11:00 ET
|
Opus Security
PALO ALTO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Opus Security, a pioneer in unified cloud-native remediation orchestration, is excited to announce its partnership with New Relic, a leading...
Foster Counseling and Therapy Announces Specialized Anxiety and OCD Services in Lake in the Hills
May 07, 2024 09:00 ET
|
Foster Counseling & Therapy
Lake in the Hills, IL, May 07, 2024 (GLOBE NEWSWIRE) -- Foster Counseling and Therapy is proud to announce its specialized services for anxiety and Obsessive-Compulsive Disorder (OCD) in the Lake...
Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102
May 07, 2024 07:00 ET
|
Verve Therapeutics
VERVE-102 is an investigational in vivo base editing medicine designed to permanently inactivate the PCSK9 gene in the liver to durably reduce blood low-density lipoprotein cholesterol Heart-2...
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
May 07, 2024 06:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024
Final Weeks to Register for this Essential 2 Day Arab Pharmacovigilance Guideline Practical Requirements Training Course (ONLINE EVENT: June 13-14, 2024)
May 07, 2024 04:02 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Practical Requirements of the Arab Pharmacovigilance Guidelines Training Course" conference has been added to ResearchAndMarkets.com's offering. On 1...
Microchip Technology Announces Financial Results For Fourth Quarter and Fiscal Year 2024
May 06, 2024 16:15 ET
|
Microchip Technology Inc.
For the quarter ended March 31, 2024 Net sales of $1.326 billion, down 24.9% sequentially and down 40.6% from the year ago quarter. Our guidance provided on February 1, 2024 was for net sales to be...
Trading in Novo Nordisk shares by board members, executives and associated persons
May 06, 2024 15:02 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk A/S - share repurchase programme
May 06, 2024 14:44 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new...